blue cross blue shield fep glp 1 coverage GLP-1 Drugs: What Employers Need to Know FEP Blue Focus Coverage and

Key findings Related Stories Study shows how stress forces brain to prioritize memories Spermidine boosts key cellular processes linked to aging in early research Moderate coffee intake may support heart health, AHA says Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Below is a Q&A with study senior author Dr

Who is an ideal candidate for Ozempic for medical weight loss

The weight is just gonna come back

A patient with previously incidental gallstones who starts high-dose GLP-1 therapy has a substantially elevated risk of developing an acute biliary event

Does injection site affect side effects like nausea

What is Semaglutide GLP-1